Literature DB >> 33497993

Corrigendum to 'Clinical significance of ERBB2 exon 16 skipping: analysis of a real-world retrospective observational cohort study': [ESMO Open Volume 5, Issue 6, 2020, e000985].

L Shi1, C Xu2, Y Ma3, Q Ou3, X Wu3, S Lu4, Y Shao5, R Guo6, J Kong7.   

Abstract

Entities:  

Year:  2021        PMID: 33497993      PMCID: PMC7838726          DOI: 10.1016/j.esmoop.2021.100052

Source DB:  PubMed          Journal:  ESMO Open        ISSN: 2059-7029


× No keyword cloud information.
  1 in total

1.  ERBB2D16 Expression in HER2 Positive Gastric Cancer Is Associated With Resistance to Trastuzumab.

Authors:  Shuo Wang; Yuze Zhao; Yuguang Song; Guoliang Qiao; Yan Di; Jing Zhao; Pingping Sun; Huixia Zheng; He Huang; Hongyan Huang
Journal:  Front Oncol       Date:  2022-04-07       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.